Avoro Capital Advisors LLC
CIK 1633313
13F filing for Q2 2026・No. 526
- Holdings
- US$11.14B
- Quarter change
- +US$971.46M
- Entries
- 26
- Net bought (estimate)
- −US$599.31M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 3
- Sold out 7
- Cut 3
- Added 11
- Corporate actions 0
- Unchanged 9
Largest holdings
26 stocks worth US$11.14B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| UTHRUNITED THERAPEUTICS CORPCommon | Added | 2,777,777 | US$1.51B | 13.52% |
| ASCENDIS PHARMAORDINARY SHARES | New | 5,111,111 | US$1.36B | 12.24% |
| KRYSKRYSTAL BIOTECH INCCommon | Unchanged | 2,888,888 | US$1.07B | 9.64% |
| MDGLMADRIGAL PHARMACEUTICALS INCCommon | Added | 1,833,333 | US$984.41M | 8.84% |
| ARGXARGENX SESponsored ADR | Unchanged | 1,000,000 | US$927.77M | 8.33% |
| ARWRARROWHEAD PHARMACEUTICALS INCCommon | Added | 11,355,555 | US$925.59M | 8.31% |
| KYMERA THERAPEUTICS INCCommon | Unchanged | 7,474,747 | US$857.13M | 7.70% |
| RVMDREVOLUTION MEDICINES INCCommon | Cut | 2,297,000 | US$430.18M | 3.86% |
| CYTOKINETICS INCCommon | Added | 4,999,999 | US$425.95M | 3.82% |
| CELCUITY INCCommon | Added | 3,400,000 | US$355.71M | 3.19% |
Sign in (free) to see its 26 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.